Literature DB >> 2688303

Experimental obesity: a homeostatic failure due to defective nutrient stimulation of the sympathetic nervous system.

G A Bray, D A York, J S Fisler.   

Abstract

The basic hypothesis of this review is that studies on models of experimental obesity can provide insight into the control systems regulating body nutrient stores in humans. In this homeostatic or feedback approach to analysis of the nutrient control system, we have examined the afferent feedback signals, the central controller, and the efferent control elements regulating the controlled system of nutrient intake, storage, and oxidation. The mechanisms involved in the beginning and ending of single meals must clearly be related to the long-term changes in fat stores, although this relationship is far from clear. Changes in total nutrient storage in adipose tissue can arise as a consequence of changes in the quantity of nutrients ingested in one form or another or a decrease in the utilization of the ingested nutrients. A change in energy intake can be effected by increased size of individual meals, increased number of meals in a 24-hour period, or a combination of these events. Similarly, a decrease in utilization of these nutrients can develop through changes in resting metabolic energy expenditure which are associated with one of more of the biological cycles such as protein metabolism, triglyceride for glycogen synthesis and breakdown, or maintenance of ionic gradients for Na+ + K+ across cell walls. In addition, differences in energy expenditure related to the thermogenesis of eating or to the level of physical activity may account for differences in nutrient utilization.

Entities:  

Mesh:

Year:  1989        PMID: 2688303     DOI: 10.1016/s0083-6729(08)60393-3

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  27 in total

1.  Reduction of food intake and weight gain by the ob protein requires a specific secondary structure and is reversible.

Authors:  K Giese; W J Fantl; C Vitt; J C Stephans; L Cousens; M Wachowicz; L T Williams
Journal:  Mol Med       Date:  1996-01       Impact factor: 6.354

2.  The adipose tissue/central nervous system axis.

Authors:  T M Loftus; D G Maggs; M D Lane
Journal:  Diabetologia       Date:  1997-10       Impact factor: 10.122

3.  Effects of metformin treatment on glucose transporter proteins in subcellular fractions of skeletal muscle in (fa/fa) Zucker rats.

Authors:  J Rouru; M Koulu; J Peltonen; E Santti; V Hänninen; U Pesonen; R Huupponen
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

4.  Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain.

Authors:  M Spraul; E Ravussin; A M Fontvieille; R Rising; D E Larson; E A Anderson
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

5.  Effects of high-isoflavone soy diet vs. casein protein diet and obesity on DMBA-induced mammary tumor development.

Authors:  Reza Hakkak; Saied Shaaf; Chan Hee Jo; Stewart Macleod; Soheila Korourian
Journal:  Oncol Lett       Date:  2010-11-08       Impact factor: 2.967

Review 6.  Neural mechanisms and management of obesity-related hypertension.

Authors:  Murray D Esler; Nina Eikelis; Elisabeth Lambert; Nora Straznicky
Journal:  Curr Cardiol Rep       Date:  2008-11       Impact factor: 2.931

7.  Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans.

Authors:  P Vollenweider; D Randin; L Tappy; E Jéquier; P Nicod; U Scherrer
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

Review 8.  Overfeeding, autonomic regulation and metabolic consequences.

Authors:  A J Scheurink; B Balkan; J H Strubbe; G van Dijk; A B Steffens
Journal:  Cardiovasc Drugs Ther       Date:  1996-06       Impact factor: 3.727

Review 9.  Molecular mapping of obesity genes.

Authors:  J M Friedman; R L Leibel; N Bahary
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

10.  Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.

Authors:  K Fujimoto; K Fukagawa; T Sakata; P Tso
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.